Analysis in a group dosing study [Bioanalytics]

posted by jag009  – NJ, 2015-07-22 18:23 (3595 d 03:48 ago) – Posting: # 15127
Views: 3,807

Hi,

❝ We are planning to conduct a FDA submission study in 3 groups (due to logistic limitations).


Is this a parallel study or a crossover study with groups?

You have a timeline issue? If not, I would prefer to finish all dosing and PK samplings before starting bioanalytical.

John

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
22 visitors (0 registered, 22 guests [including 8 identified bots]).
Forum time: 22:12 CEST (Europe/Vienna)

An expert is someone who knows some of the worst mistakes
that can be made in his subject,
and how to avoid them.    Werner Heisenberg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5